Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
135.8 EUR | -0.75% | -1.10% | -3.46% |
02/07 | J&J: promising results in multiple myeloma | CF |
02/07 | Johnson & Johnson Says Interim Analysis of Blood Cancer Therapy Study Show Promise | MT |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Turnover
EBIT
Dividend / Share (DPS)
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- Revisions Johnson & Johnson